(b) The proportional of the abnormality of lipid profile level among study groups at baseline

Lipid name	HIV+TB+ (n = 44)	HIV−TB+ (n = 49)	HIV+TST+ (n = 17)	HIV−TST+ (n = 24)	HIV−TST− (n = 25)	P value using Pearson Chi2
TC < 130 mg/dl, N (%)	38 (86)	36 (73)	11 (65)	2 (8)	4 (4)	<0.001
TC ≥ 200 mg/dl, N (%)	0 (0)	0 (0)	0 (0)	1 (4)	6 (24)	<0.001
TG < 90 mg/dl, N (%)	30 (68)	40 (82)	13 (76)	14 (58)	8 (32)	0.001
TG ≥ 150 mg/dl, N (%)	0 (0)	0 (0)	0 (0)	2 (8)	2 (8)	0.056
LDL < 100 mg/dl, N (%)	43 (98)	46 (94)	15 (88)	19 (79)	17 (68)	0.002
LDL ≥ 130 mg/dl, N (%)	0 (0)	1 (2)	0 (0)	1 (4)	1 (4)	0.652
HDL < 40 mg/dl, N (%)	43 (98)	43 (88)	13 (76)	10 (42)	9 (36)	<0.001
HDL > 40 mg/dl, N (%)	1 (2)	6 (12)	4 (24)	14 (58)	16 (64)	0.000
TC < 130 & TG < 90 & LDL < 100 & HDL < 40	25 (40)	28 (44)	8 (13)	2 (3)	0 (0)